Developed in conjunction with Vanderbilt University, the 16-item Patient-Reported Arthralgia Inventory (PRAI) was designed to measure arthralgia severity in 16 joints in the context of a longitudinal cohort study to assess aromatase inhibitor-associated arthralgia in breast cancer survivors and arthralgia in postmenopausal women without breast cancer.
Patient-Reported Arthralgia Inventory (PRAI)
NUMBER OF ITEMS:
Patients 18 years and older with arthralgia
Past 7 days
10 point rating scale
Paper and electronic
Self-administration and interview when applicable
TIME FOR COMPLETION:
Manual scoring template
Available translations of the PRAI can be obtained when licensing the measure. Users are not permitted to translate the PRAI without prior permission from FACIT.org. Permission may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor of the PRAI.
Please contact us for more information.
Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.
Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.
To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.
Castel LD, Wallston KA, Saville BR, Alvarez JR, Shields BD, Feurer ID, Cella D. Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia. Patient Relat Outcome Meas. 2015 Jul 28;6:205-14. doi: 10.2147/PROM.S47997. PMID: 26251635; PMCID: PMC4524452.